Skip to content

Effectiveness of High-Intensity Focused Electromagnetic HIFEM in Women with Stage I-II Pelvic Organ Prolapse

Effectiveness of High-Intensity Focused Electromagnetic HIFEM in Women with Stage I-II Pelvic Organ Prolapse

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260209006
Enrollment
72
Registered
2026-02-09
Start date
2026-02-18
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse Pelvic floor dysfunction Pelvic floor Pelvic organ prolapse Pelvic floor muscle training Electromagnetic stimulation Transperineal ultrasound Quality of life

Interventions

Participants assigned to this arm will receive high intensity focused electromagnetic therapy applied to the pelvic floor combined with standardized pelvic floor muscle training according to the study
Experimental Device,Sham Comparator Device
High intensity focused electromagnetic therapy plus pelvic floor muscle training,Sham electromagnetic therapy plus pelvic floor muscle training

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor
BTL Medical Technologies (in-kind HIFEM device support),GE Medical Systems (Thailand) Ltd. (in-kind ultrasound equipment support)
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Women 18 years old with symptomatic anterior compartment POP Q Stage I and II POP Q Stage I and II as defined by the Pelvic Organ Prolapse Quantification system, diagnosed by clinical examination and symptoms defined by Thai ICIQ VS Question no. 6 presence of vaginal bulge 2.Able and willing to provide written informed consent. 3.Recruited from the Female Pelvic Medicine and Reconstructive Surgery outpatient clinic, Department of Obstetrics and Gynaecology, Ramathibodi Hospital.

Exclusion criteria

Exclusion criteria: 1.POP-Q Stage III or greater (as defined by the POP-Q system) 2.Prior POP surgery <1 year 3.Current pessary use with inability or unwillingness to discontinue use for the entire study period (from baseline through the 12-week follow-up) 4.Contraindications to HIFEM (pacemaker, metallic implants, pregnancy, infection, epilepsy) 5.Inability to perform pelvic floor muscle training (PFMT) as instructed 6.Malignancy 7.Inability to undergo TPUS/perineometry 8.Postpartum women (<6 months after delivery) 9.Previous treatment with high-intensity focused electromagnetic (HIFEM) therapy

Design outcomes

Primary

MeasureTime frame
Change in Pelvic Floor Disability Index twenty total score Baseline and twelve weeks post intervention Pelvic Floor Distress Inventory twenty total score Thai validated questionnaire

Secondary

MeasureTime frame
Change in pelvic floor ultrasound parameters Baseline and twelve weeks post intervention Transperineal ultrasound assessment of anteroposterior diameter laterolateral diameter bladder neck descent and anterior compartment descent,Change in pelvic floor muscle strength Baseline and twelve weeks post intervention Perineometry assessment of pelvic floor muscle contraction strength,Change in quality of life scores Baseline and twelve weeks post intervention International Consultation on Incontinence Questionnaire Vaginal Symptoms and Prolapse Quality of Life questionnaires Thai validated versions

Countries

Thailand

Contacts

Public ContactPhatcha Tontapanit

Ramathibodi Hospital Mahidol University

primnnproper@gmail.com6022012167

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026